AI assistant
Hansa Biopharma Major Shareholding Notification 2023
3057_iss_2023-11-13_5c96ea68-074e-4e66-9bf4-35dee483a325.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
Issuer Hansa Biopharma AB
Holder
Avanza Bank Holding AB för Försäkringsaktiebolaget Avanza Pension
Instrument
| Instrument | Aktier | |
|---|---|---|
| Before the transaction | ||
| Shares | Data not given* | |
| Voting rights | Data not given* | |
| Transaction | ||
| Reason for major shareholding notification Sell | ||
| Date | 10/11/2023 | |
| Limit for number of shares | 5 % | |
| After the transaction | ||
| Quantity | ||
| Shares | 1,059,591 | |
| Directly held voting rights | 0 | |
| Indirectly held voting rights | 1,059,591 | |
| Percentage | ||
| Directly held shares | 1.92533 % | |
| Directly held voting rights | 0 % | |
| Indirectly held voting rights | 2.0027 % |
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
|
|---|---|---|
| Shares | 2.0027 % | 1,059,591 |
| Instruments - FITA Ch. 4, section 2, first paragraph, line 2 |
||
| Instruments - FITA Ch. 4, section 2, first paragraph, line 3 |
||
| - Physically settled - Cash settled |
3.17893 % | 1,681,908 |
| Total | 5.18163 % | 2,741,499 |
Group total holdings
Voting rights 2,741,499
Percentage of voting rights 5.18163
Notes (other relevant informations according to law)
Flaggning sker för passerat tröskelvärde beträffande det aggregerade innehavet. Aktierna, samt övriga instrument enligt LHF 4 kap, 2§ första stycket 1 och finansiella instrument enligt LHF 4 kap. 2§ första stycket 3 innehas av Försäkringsaktiebolaget Avanza Pension som är ett helägt dotterbolag till Avanza Bank Holding AB (publ). Det är försäkringskunder som via depåfullmakt avyttrat de aktuella värdepapperna.
Published
13/11/2023 10:23
Contact
Name Marie Andersson
Email [email protected]
*Source of information has chosen not to submit the data
[email protected] Tfn 08-408 980 37 Fax 08-24 39 25